Martin Madaus

Martin Madaus

Directeur Général chez AZENTA, INC.

Fortune : 3 M $ au 31/08/2026

66 ans
Health Technology
Commercial Services
Health Services

Profil

Martin D.
Madaus
is President, Chief Executive Officer & Director at Azenta, Inc. since 2026.
He is Chairman of Repligen Corp.
starting in 2026.
He serves as Executive Chairman at Emulate, Inc. since 2020.
He holds director positions at Candela Corp., Massachusetts High Technology Council, Inc., Unchained Labs LLC since 2021, Ultivue, Inc., Candela Medical, Inc. since 2018, Syntis Bio, Inc., Haemonetics Corp.
starting in 2026, and is Senior Operating Executive at The Carlyle Group Inc. since 2019.
Former roles include Chairman, President & Chief Executive Officer at EMD Millipore Corp.
in 2010; Chairman & Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. from 2014 to 2019; President & Chief Executive Officer at Roche Diagnostics Corp.
from 2000 to 2004; Chairman, President & Chief Executive Officer at Millipore SA from 2005 to 2010; Independent Director at Mettler-Toledo International, Inc. from 2011 to 2015; Independent Director at Covidien Unlimited Co. from 2011 to 2014; Independent Director at Standard BioTools, Inc. from 2022 to 2024; Independent Director at Hologic, Inc. from 2024 to 2026; Director at Quanterix Corp.
from 2010 to 2025; Chief Operations Officer at Sherlock Biosciences, Inc. from 2020 to 2021; Vice President-Business Development at Roche Molecular Systems, Inc.; Director at Pharmaceutical Product Development LLC, New England Healthcare Institute, Massachusetts Technology Collaborative, Predictive Biosciences, Inc., Young Men's Christian Association of Greater Boston, Inc., and Analytical Life Science & Diagnostics Association.
Education includes doctorates from Ludwig-Maximilians-Universität München in 1985 and The University of Veterinary Medicine Hanover.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/05/2026 8 392 ( 0,01 % ) 2 M $ 31/08/2026
22/09/2026 42 602 ( 0,1 % ) 1 M $ 31/08/2026
24/07/2026 2 538 ( 0,01 % ) 261 592 $ 31/08/2026

Postes actifs de Martin Madaus

SociétésPosteDébut
CANDELA MEDICAL, INC. Directeur/Membre du Conseil 01/05/2018
REPLIGEN CORPORATION Président 13/03/2026
AZENTA, INC. Directeur Général 22/08/2026
HAEMONETICS CORPORATION Directeur/Membre du Conseil 24/07/2026
THE CARLYLE GROUP INC. Corporate Officer/Principal 01/01/2019
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/07/2021
Directeur/Membre du Conseil -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░

Anciens postes connus de Martin Madaus

SociétésPosteFin
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Martin Madaus

Formation de Martin Madaus

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

64

Relations au 1er degré

31

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées31

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Finance

Analytical Life Science & Diagnostics Association

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Martin Madaus
🔇